Peroxiredoxin 2 is involved in vasculogenic mimicry formation by targeting VEGFR2 activation in colorectal cancer

MiR-124 represses vasculogenic mimicry and cell motility by targeting amotL1 in cervical cancer cells

(2014) Hai-Ying Wan et al.   CANCER LETTERS

Regulation of the ROS Response Dynamics and Organization to PDGF Motile Stimuli Revealed by Single Nanoparticle Imaging

(2014) Cedric I. Bouzigues et al.   CHEMISTRY & BIOLOGY

Vascular channels formed by subpopulations of PECAM1+ melanoma cells

(2014) James M. Dunleavey et al.   Nature Communications

Peroxiredoxin 2 knockdown by RNA interference inhibits the growth of colorectal cancer cells by downregulating Wnt/β-catenin signaling

(2013) Weidong Lu et al.   CANCER LETTERS

Over-expression of survivin and VEGF in small-cell lung cancer may predict the poorer prognosis

(2013) Ping Chen et al.   MEDICAL ONCOLOGY

Peroxiredoxin 2 is upregulated in colorectal cancer and contributes to colorectal cancer cells’ survival by protecting cells from oxidative stress

(2013) Weidong Lu et al.   MOLECULAR AND CELLULAR BIOCHEMISTRY

Vascular Endothelial Growth Factor Receptor 2 (VEGFR-2) Plays a Key Role in Vasculogenic Mimicry Formation, Neovascularization and Tumor Initiation by Glioma Stem-like Cells

(2013) Xiaohong Yao et al.   PLoS One

Vascular endothelial growth factor A, secreted in response to transforming growth factor-β1 under hypoxic conditions, induces autocrine effects on migration of prostate cancer cells

(2012) Eric Darrington et al.   ASIAN JOURNAL OF ANDROLOGY

Tubular network formation by adriamycin-resistant MCF-7 breast cancer cells is closely linked to MMP-9 and VEGFR-2/VEGFR-3 over-expressions

(2012) Asmae Karroum et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

Glioblastoma-derived Tumor Cells Induce Vasculogenic Mimicry through Flk-1 Protein Activation

(2012) Ralph Francescone et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Zinc finger E-box binding homeobox 1 promotes vasculogenic mimicry in colorectal cancer through induction of epithelial-to-mesenchymal transition

(2011) Zhiyong Liu et al.   CANCER SCIENCE

Prognostic Role of Vasculogenic Mimicry in Colorectal Cancer

(2011) Coen I. M. Baeten et al.   DISEASES OF THE COLON & RECTUM

Peroxiredoxin II Is an Essential Antioxidant Enzyme that Prevents the Oxidative Inactivation of VEGF Receptor-2 in Vascular Endothelial Cells

(2011) Dong Hoon Kang et al.   MOLECULAR CELL

Specific expression profile and prognostic significance of peroxiredoxins in grade II-IV astrocytic brain tumors

(2010) Sally Järvelä et al.   BMC CANCER

Functional significance of VEGF-a in human ovarian carcinoma: Role in vasculogenic mimicry

(2010) Jun-yan Wang et al.   CANCER BIOLOGY & THERAPY

Inactivation of Peroxiredoxin I by Phosphorylation Allows Localized H2O2 Accumulation for Cell Signaling

(2010) Hyun Ae Woo et al.   CELL

VEGF receptor signaling links inflammation and tumorigenesis in colitis-associated cancer

(2010) Maximilian J. Waldner et al.   JOURNAL OF EXPERIMENTAL MEDICINE

Expression and functional significance of Twist1 in hepatocellular carcinoma: Its role in vasculogenic mimicry

(2009) Tao Sun et al.   HEPATOLOGY

Revised TN Categorization for Colon Cancer Based on National Survival Outcomes Data

(2009) Leonard L. Gunderson et al.   JOURNAL OF CLINICAL ONCOLOGY

Role and mechanism of vasculogenic mimicry in gastrointestinal stromal tumors

(2008) Baocun Sun et al.   HUMAN PATHOLOGY